We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
A picture of Michele Trott, PhD

Michele Trott, PhD profile page


Michele Trott (nee Wilson) is a New Zealand-based science writer who pursues freelance writing projects alongside her in-house role as a scientific content writer at Izon Science. After completing her PhD (Endocrinology) at Lincoln University (NZ), Michele began pursuing her science writing career with Technology Networks in the UK. There, she spent 12 months covering a maternity leave role as a science editor, and managed the cell science, biopharma and diagnostics communities. Upon her arrival back in NZ, Michele established “Choice Science Writing” and became a full-time freelance science writer, working with life science marketing agencies, biotech companies – and of course, Technology Networks – to produce engaging articles and blog posts. In April 2021, she took up the opportunity to join the team at Izon Science, a company that enables the precise separation and analysis of extracellular vesicles and other nanoparticles.


Got a Question for Michele Trott, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly.



Published Content
Total: 111
Article

A Controversial World-first: Gene-Edited Human Babies

A Chinese scientist, He Jiankui, has claimed that he helped make the world-first gene-edited babies: two twin baby girls. Reportedly, he used CRISPR-Cas9 to edit embryos for seven couples during IVF fertility treatment, and engineered the embryos to possess resistance to HIV infection. He Jiankui, from the Southern University of Science and Technology, is now facing investigation over whether the experiment was illegal.
Article

A Controversial World-first: Gene-Edited Human Babies

A Chinese scientist, He Jiankui, has claimed that he helped make the world-first gene-edited babies: two twin baby girls. Reportedly, he used CRISPR-Cas9 to edit embryos for seven couples during IVF fertility treatment, and engineered the embryos to possess resistance to HIV infection. He Jiankui, from the Southern University of Science and Technology, is now facing investigation over whether the experiment was illegal.
Startup Slam: The Dragons’ Den of Biopharma in Europe content piece image
Listicle

Startup Slam: The Dragons’ Den of Biopharma in Europe

Of 60 applications from across 17 countries, there were eight finalists who participated in the 'Startup Slam' — the Dragons' Den of Biopharma. Representatives of biotech companies presented to a jury of leading investors, pharma deal-makers and biotech business key opinion leaders at the BIO-Europe conference in Copenhagen, November 2018.
Startup Slam: The Dragons’ Den of Biopharma in Europe content piece image
Listicle

Startup Slam: The Dragons’ Den of Biopharma in Europe

Of 60 applications from across 17 countries, there were eight finalists who participated in the 'Startup Slam' — the Dragons' Den of Biopharma. Representatives of biotech companies presented to a jury of leading investors, pharma deal-makers and biotech business key opinion leaders at the BIO-Europe conference in Copenhagen, November 2018.
Separation in Bioprocessing content piece image
Infographic

Separation in Bioprocessing

This infographic provides an overview of the processes behind the large-scale purification of biologically-derived products.
Entering the Golden Era of Lateral Flow Diagnostics content piece image
Industry Insight

Entering the Golden Era of Lateral Flow Diagnostics

Gold nanorods are increasingly being used in diagnostic applications, such as lateral flow assays. To learn more, we got in touch with Darren Rowles, CEO of Sona Nanotech Inc. who provides insights on diagnostic industry trends, and tells us about the source, application and production process of gold nanoparticles.
News

Proactive Approach Protects Population From HIV

A preventative approach to HIV drastically reduced the number of HIV diagnoses in New South Wales, Australia.
News

Timeline Predicted for Cervical Cancer Elimination in Australia

Australia could become the first country in the world to eliminate cervical cancer as a public health problem, according to a comprehensive analysis of HPV vaccination, natural history and cervical screening.
Developing Stem Cell Therapy Solutions for Liver Disease content piece image
Industry Insight

Developing Stem Cell Therapy Solutions for Liver Disease

We spoke with Eric Schuur, President and CEO of HepaTx, to learn how the company hopes to develop regenerative medicine solutions for people with liver disease. Eric provides an overview of the steps involved in hepatocyte production and provides insights on the hurdles that need to be overcome, to get these stem cells from the lab to the clinic.
Developing Stem Cell Therapy Solutions for Liver Disease content piece image
Industry Insight

Developing Stem Cell Therapy Solutions for Liver Disease

We spoke with Eric Schuur, President and CEO of HepaTx, to learn how the company hopes to develop regenerative medicine solutions for people with liver disease. Eric provides an overview of the steps involved in hepatocyte production and provides insights on the hurdles that need to be overcome, to get these stem cells from the lab to the clinic.
Advertisement